FDA approves Abilify for treating children with autism

11/23/2009 | Bloomberg Businessweek · Disability Scoop

The FDA approved the drug Abilify for treating aggression and irritability in children ages 6 to 17 who have autism. The approval was based on two studies that showed Abilify, commonly used to treat schizophrenia, depression and bipolar disorder, improved irritability in patients given the drug compared with those given a placebo. The drug's makers said the medication should be used in combination with psychological, social and educational therapies.

View Full Article in:

Bloomberg Businessweek · Disability Scoop

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Program Officer, Teacher Development
Knowles Science Teaching Foundation
Moorestown, NJ
Production Manager, Education and Leadership
Asia Society
New York, NY
CONTRACT - Education Consultants
Confidential
East Coast, Phoenix, Los Angeles, SL_Multiple Locations
Inside Sales Representative
Apperson, Inc.
Multiple Locations, SL_Multiple Locations
Product Marketing Manager
Apperson, Inc.
Charlotte, NC